6-Amino-5-bromoquinoxaline

We are 6-Amino-5-bromoquinoxaline CAS:50358-63-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:6-Amino-5-bromoquinoxaline
CAS.NO:50358-63-9
Synonyms:6-Amino-5-bromoquinoxaline
5-Bromoquinoxalin-6-amine
5-Bromo-6-quinoxalinamine
 
Physical and Chemical Properties:
Density 1.7±0.1 g/cm3
Boiling Point 367.0±37.0 °C at 760 mmHg
Melting Point 151-153°C
Molecular Formula C8H6BrN3
Molecular Weight 224.057
Flash Point 175.8±26.5 °C
Vapour Pressure 0.0±0.8 mmHg at 25°C
Index of Refraction 1.747
 
Specification:
Appearance:Light yellow to brown powder
Assay(HPLC):≥99.0%
Loss on drying:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Brimonidine tartrate(CAS:70359-46-5).

6-Amino-5-bromoquinoxaline


Related News: Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.4-(orthodimethylphosphinylanilino)-5-chloro-2-chloropyrimidine China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.610-97-9 You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs.28721-08-6 According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.

Related Products
Product Name
N,N-dimethylformamide View Details
3-Bromo-4-Chloro-Benzaldehyde View Details
3-Fluorophenylboronic acid View Details
1-Methyl-1H-imidazole-2-carboxylic acid manufacturer 2-(2,2,2-Trifluoroethoxy)phenol manufacturer 1,6-Dibromohexane manufacturer 2-Chloro-5-(chloromethyl)thiazole manufacturer 2-(4-bromophenyl)-4-phenylquinazoline manufacturer